Life Sciences Artificial Intelligence (AI) Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Life Sciences Artificial Intelligence (AI) Market
Life Sciences Artificial Intelligence (AI) Market: By Type (Machine Learning (ML), Deep Learning (DL), Neural Networks (NN)); By Three-Wave Process (First Wave, Second Wave, Third Wave); By Application (Discovery, Pre – Clinical, Clinical, Regulatory Approval, and Patients); By Geography - Forecast(2018-2024)
Report Code : ITR 0175
Updated Date: 31 May, 2018  

1. Life Sciences AI Market Overview
2. Executive Summary
3. Life Sciences AI Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Life Sciences AI Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Life Sciences AI – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Life Sciences AI – Regulatory Analysis
7. Life Sciences AI Market - By Type
   7.1. Introduction
   7.2. Machine Learning
      7.2.1. Diagnosis and Disease Identification
      7.2.2. Personalized Medicine
      7.2.3. Drug Discovery 
      7.2.4. Clinical Trials
      7.2.5. Radiotherapy and Radiology
      7.2.6. Electronic Health Records
      7.2.7. Others
   7.3. Deep Learning
   7.4. Neural Networks
8. Life Sciences AI Market - By process
   8.1. Introduction
   8.2. First Wave
   8.3. Second Wave
   8.4. Third Wave
9. Life Sciences AI Market - By End-User Application
   9.1. Introduction
   9.2. Drug Discovery
      9.2.1. Identify Unmet Medical Needs
      9.2.2. Target Identification
      9.2.3. Target Validation
      9.2.4. Assay Development to Identify Models
      9.2.5. Lead Identification
      9.2.6. Lead Optimization
      9.2.7. Safety/Efficacy Studies
   9.3. Pre -Clinical 
      9.3.1. In Vitro Studies
      9.3.2. In Vivo Studies
      9.3.3. Pharmacokinetic Studies 
      9.3.4. Absorption, Distribution, Metabolism, Excretion (ADME) Studies
      9.3.5. Formulation Delivery, Packaging Development
      9.3.6. Investigation New Drug (IND) Process
   9.4. Clinical
      9.4.1. Design Trails
      9.4.2. Patient Identification
      9.4.3. Patient Enrollment
      9.4.4. Execution of Trails
      9.4.5. Data Collection & Analytics
   9.5. Drug Approval
      9.5.1. Data Reporting
      9.5.2. Approval of Application and Process
      9.5.3. Labeling
      9.5.4. Safety Updates
      9.5.5. FDA Approval
   9.6. Patient Monitoring
      9.6.1. Preventive Medicine
      9.6.2. Personalized Medicine
      9.6.3. Beyond the Bill
      9.6.4. Patient Identification
      9.6.5. Patient Engagement
      9.6.6. Disease Diagnosis & Management
   9.7. Others
      9.7.1. Diagnosis & Disease Identification
      9.7.2. Personalized Medicine
      9.7.3. Electronic Health Records
10. Distance Measurement Sensor Market - By Geography
   10.1. North America
      10.1.1. U.S.
      10.1.2. Canada
      10.1.3. Mexico
   10.2. South America
      10.2.1. Brazil
      10.2.2. Argentina
      10.2.3. Chile
      10.2.4. Rest of South America
   10.3. Europe
      10.3.1. U.K.
      10.3.2. Germany
      10.3.3. Italy
      10.3.4. France
      10.3.5. Nordic
      10.3.6. Russia
      10.3.7. Eastern Europe
      10.3.8. Switzerland
      10.3.9. Belgium
      10.3.10. Rest of Europe
   10.4. APAC
      10.4.1. Japan
      10.4.2. China
      10.4.3. India
      10.4.4. South Korea
      10.4.5. Taiwan
      10.4.6. Southeast Asia
      10.4.7. Australia
      10.4.8. New Zealand 
      10.4.9. Rest of APAC
   10.5. ROW
      10.5.1. Middle East
            10.5.1.1. Saudi Arabia 
            10.5.1.2. U.A.E
            10.5.1.3. Qatar
            10.5.1.4. Rest of Middle East
      10.5.2. Africa
            10.5.2.1. South Africa
            10.5.2.2. Nigeria
            10.5.2.3. Egypt
            10.5.2.4. Rest of Africa
11. Market Entropy
   11.1. New Product Launches
   11.2. M&As, Collaborations, JVs, Partnership
12. Company Profiles
   12.1. TwoXAR
   12.2. Numerate
   12.3. NuMedii
   12.4. IBM
   12.5. Envisagenics
   12.6. Company 6
   12.7. Company 7
   12.8. Company 8
   12.9. Company 9
   12.10. Company 10
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll